Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 15, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, August 14, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Dewey Steadman Maintained (AMRX) at Hold with Increased Target to $21 on, Aug 14th, 2018
Dewey Steadman of Canaccord Genuity, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Increased Target from $18 to $21 on, Aug 14th, 2018.
Dewey has made no other calls on AMRX in the last 4 months.
There are 4 other peers that have a rating on AMRX. Out of the 4 peers that are also analyzing AMRX, 1 agrees with Dewey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $20 on, Friday, August 10th, 2018
These are the ratings of the 3 analyists that currently disagree with Dewey
- Randall Stanicky of "RBC Capital" Upgraded from Hold to Buy on, Monday, August 13th, 2018
- David Risinger of "Morgan Stanley" Initiated at Buy and Held Target at $22 on, Monday, July 23rd, 2018
- David Buck of "B. Riley Securities" Initiated at Strong Buy and Held Target at $26 on, Friday, June 22nd, 2018
